Xeris Biopharma Holdings Inc (XERS)

Investing Cash Flow

-$209.00K

Quarterly · Period ending: · USD

XERS logo

XERS Investing Cash Flow

Latest reported-$209.00K
XERS Quarterly Cash from Investing (-$342.00K → -$209.00K)
High-resolution chart · PNG

XERS investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-209,000
-325,000
-333,000
-71,000
-279,000
-13,000
10,016,000
9,914,000
4,603,000
-19,650,000
14,868,000
14,655,000
8,452,000
-43,979,000
9,168,000
6,709,000
11,868,000
6,716,000
36,602,000
18,505,000
16,556,000
26,301,000
7,249,000
-60,674,000
17,344,000
8,676,000
-9,041,000
-2,496,000
27,879,000
-18,725,000
-11,723,000
-56,049,000
-156,000
-333,000
-236,000
-25,000
-97,000
-342,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.